NCT06788470View on ClinicalTrials.gov

Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stem Cell(MSC) Transplantation in the Treatment of Bronchopulmonary Dysplasia(BPD) in Premature Infants

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

August 9, 2024

Primary Completion Date

August 9, 2027

Study Completion Date

August 9, 2027

Conditions
BPD - Bronchopulmonary Dysplasia
Interventions
DRUG

MSC

Intratracheal administration of umbilical cord-derived mesenchymal stem cells (MSCs).

Trial Locations (1)

310052

RECRUITING

The Children's Hospital of Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
lead

The Children's Hospital of Zhejiang University School of Medicine

OTHER